Prospective clinical research on safety and efficacy of TAPCOM Combination Ophthalmic Solution switched from Xalatan Ophthalmic Solution
Phase of Trial: Phase II
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Tafluprost/timolol (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions; Therapeutic Use
- 03 Aug 2017 Status changed from active, no longer recruiting to completed.
- 31 Mar 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 10 Feb 2015 New trial record